Related Experiment Video
Updated: Jul 28, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Humoral immunity and bronchiectasis.
A Stead1, J G Douglas, C J Broadfoot
1Aberdeen College, Gallowgate Centre, Aberdeen, UK.
Antibody deficiency is uncommon in adults with bronchiectasis. This study found that routine immunological testing for antibody deficiency in these patients is not generally recommended, especially after age 40.
Area of Science:
- Immunology
- Pulmonology
- Medical Diagnostics
Background:
- Bronchiectasis is a known complication of primary antibody deficiency.
- The frequency of antibody deficiency as a cause of bronchiectasis is not well-defined.
- Assessing the need for immunological investigation in bronchiectasis patients is important.
Purpose of the Study:
- To investigate the humoral immune status of bronchiectasis patients.
- To determine the frequency of significant antibody deficiency in this cohort.
- To assess the appropriateness of routine immunological investigations for bronchiectasis.
Main Methods:
- Serum immunoglobulins, IgG subclasses, and specific antibodies to Haemophilus influenzae and Streptococcus pneumoniae were measured in 56 outpatients.
- Vaccination responses were quantified in patients with low antibody levels.
- Patients had a mean age of 59.6 years.
Main Results:
- Three patients (3/56) had low total serum IgG.
- Thirteen patients (13/56) had IgG subclass deficiencies, most commonly IgG4 (9/56).
- Twenty-nine patients (29/56) had low basal specific polysaccharide antibody levels, with one showing a specific defect in response to pneumococcal polysaccharide vaccine.
Conclusions:
- Antibody deficiency is an uncommon etiological factor in bronchiectasis beyond the fourth decade.
- Routine detailed investigation of humoral immune status is not generally justified in adult bronchiectasis patients.
- The findings suggest a selective approach to immunological testing in this population.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
08:42Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
Related Concept Videos
Humoral Immune Responses
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Microbiota of the Respiratory Tract
Tuberculosis
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features